Ascendis Pharma A/S (ASND)
238.76
-7.38
(-3.00%)
USD |
NASDAQ |
May 08, 16:00
238.49
-0.27
(-0.11%)
After-Hours: 20:00
Ascendis Pharma EPS Diluted (Quarterly) : -0.6364 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Rhythm Pharmaceuticals, Inc. | -0.8348 |
| Evaxion AS | -0.8933 |
| IO Biotech, Inc. | -0.1252 |
| Amarin Corp. Plc | -0.501 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.06M |
| Revenue (Quarterly) | 288.07M |
| Total Expenses (Quarterly) | 327.14M |
| Enterprise Value | 15.51B |
| Gross Profit Margin (Quarterly) | 88.91% |
| Profit Margin (Quarterly) | -13.56% |
| Earnings Yield | -1.76% |
| Normalized Earnings Yield | -1.758 |